Generics 28

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Trazodone manufacturers

28 products found

Filters

28 products found

trazodone

Capsules 50 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
Germany , Poland , United Kingdom , Vietnam
Available for
Distribution only
Comments
Ref. Molipaxin
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

trazodone

Tablets 50 mg, 100 mg, 150 mg, 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
Germany , Poland , United Kingdom , Vietnam
Available for
Distribution only
Comments
Ref. Molipaxin
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

trazodone

Tablets, extended release (ER) 75 mg, 150 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Albania , Andorra , Austria , Belarus , Belgium , Bosnia And Herzegovina , Bulgaria , Croatia , Cyprus , Czech Republic , France , Greece , Hungary , Italy , Kosovo , Liechtenstein , Luxembourg , North Macedonia , Malta , Montenegro , Monaco , Netherlands , Poland , Portugal , Romania , Russia , Serbia , San Marino , Slovakia , Slovenia , Spain , Switzerland , Ukraine , United Kingdom
Available for
Licensing with supply, Distribution only
Manufacturer #573
A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, Africa, and Asia for 30+ years. Key production lines are Rx and nutraceuticals. Main therapeutic areas include CNS and respiratory. Main dosage forms include sterile forms and oral solid. The company's production lines are EU GMP-compliant. The company owns 10+ branches in Europe.

Manufacturer usually replies in 7 days

trazodone

Tablets, extended release (ER) 75 mg, 150 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Comments
Ref. Trittico
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

trazodone

Oral solution 50 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Molipaxin ®
Manufacturer #337
A pharmaceutical manufacturer based in the EU that has been active in 90+ countries selling its products in the EU, Africa, North America, Middle East, and Asia for 30+ years. Key production lines are Rx and OTC. Main therapeutic areas include diabetes, CNS, and dermatology. The company's production lines are GMP-compliant. The company possesses branches in the Middle East and Asia.

Manufacturer usually replies in 5 days

trazodone

Tablets, extended release (ER) 150 mg, 300 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply, Distribution only
Comments
The development of Trazodone XR is on hold currently. Would the company be interested with co-development ?
Manufacturer #11864
A pharmaceutical manufacturer based in the EU that is active in 20+ countries worldwide selling its products in EU, CIS, LATAM, and South-East Asia for 30+ years. Key production lines are Rx medicines, OTC drugs, and dietary supplements with EU GMP certification. The company's main therapeutic areas include oncology, cardiology, psychiatry, and internal medicine. The company provides eCTD format dossiers as well as BE studies and stability studies.

Manufacturer usually replies in 7 days

trazodone

Tablets, extended release (ER) 150mg, 300mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Unavailable markets
Austria , Bulgaria , Czech Republic , Greece , Italy , Poland , Portugal , Romania , Slovakia , Slovenia , Spain , United Kingdom , United States
Manufacturer #457

Manufacturer usually replies in 2 days

trazodone

Solution for injection 50mg/5ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Unavailable markets
Portugal , Italy , Spain , Austria , Bulgaria , Czech Republic , Greece , Poland , Romania , Slovakia , Slovenia , United States
Manufacturer #457

Manufacturer usually replies in 2 days

trazodone

Tablets 50mg, 100mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Unavailable markets
Portugal , Italy , Spain , Austria , Bulgaria , Czech Republic , Greece , Poland , Romania , Slovakia , Slovenia , United States
Manufacturer #457

Manufacturer usually replies in 2 days

trazodone

Oral drops 6%

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Unavailable markets
Portugal , Italy , Spain , Austria , Bulgaria , Czech Republic , Greece , Poland , Romania , Slovakia , Slovenia , United States
Manufacturer #457

Manufacturer usually replies in 2 days

trazodone

Tablets, prolonged release (PR) 75mg,150mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Unavailable markets
Portugal , Spain , Italy , Austria , Bulgaria , Czech Republic , Greece , Poland , Romania , Slovakia , Slovenia , United Kingdom
Manufacturer #457

Manufacturer usually replies in 2 days

trazodone

Tablets 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Bolivia , Chile , Colombia , Costa Rica , Dominican Republic , El Salvador , Guatemala , Honduras , Nicaragua , Panama , Paraguay , Peru , Ukraine , Uruguay , Venezuela
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

trazodone

Oral solution 50mg, 100mg, 150mg / 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Manufacturer #42

Manufacturer usually replies in 5 days

trazodone

Tablets 150 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #21496

It's a fully integrated pharmaceutical corporation with a global reach. The company specializes in CMO and CDMO pharmaceutical preparations in a variety of dosage forms for a variety of therapeutic categories. GSK, Pfizer, Sanofi, Novartis, Mylan, Apotex, Adcock Ingram, and other MNCs manufacture formulations in various dosage forms for customers in 55 countries in important markets such as Europe, Australia & New Zealand, Canada, Japan, Far East Asia, GCC, Africa, LATAM, and CIS.

Manufacturer usually replies in 9 days

trazodone

Capsules 50 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #21496

It's a fully integrated pharmaceutical corporation with a global reach. The company specializes in CMO and CDMO pharmaceutical preparations in a variety of dosage forms for a variety of therapeutic categories. GSK, Pfizer, Sanofi, Novartis, Mylan, Apotex, Adcock Ingram, and other MNCs manufacture formulations in various dosage forms for customers in 55 countries in important markets such as Europe, Australia & New Zealand, Canada, Japan, Far East Asia, GCC, Africa, LATAM, and CIS.

Manufacturer usually replies in 9 days

trazodone

Tablets 50 mg, 75 mg , 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Comments
Reference product : Desyrel (BMS)
Manufacturer #278

The company has become a prominent partner of the pharmacy community in North America, with the fastest rising market share among generic leaders. It can provide best-in-class supply reliability thanks to production capacity. In more than 50 countries, it's available locally or through corporate partnerships. R&D expenditures range from $40 million to $50 million per year. They are dedicated to maintaining a customer satisfaction rate of over 95% by continuously enhancing supply chain efficiency.

Manufacturer usually replies in 7 days

trazodone

Capsules 50 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Registered in
United Kingdom
Comments
Ref : Molipaxin® 100 mg, 50 mg, Capsules, Zentiva,EU
Manufacturer #12311

Manufacturer usually replies in 13 days

trazodone

Oral solution 50 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Registered in
United Kingdom
Manufacturer #12311

Manufacturer usually replies in 13 days

trazodone

Tablets, immediate release (IR) 150 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Registered in
United Kingdom
Manufacturer #12311

Manufacturer usually replies in 13 days

trazodone

Tablets 25 mg, 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19372

Manufacturer usually replies in 7 days

Want to view all 28 products? Create your free account today!

Trazodone Manufacturers

Trazodone is sold by manufacturers under several brand names. It is primarily used for treating depression, alcohol dependence, and anxiety disorders. This drug also has sedating effects. It works by altering the chemicals in the brain that may become unbalanced in individuals suffering from depression. At the same time, the drug can also help in improving energy levels, appetite, and mood. This is achieved mainly by producing serotonin in the brain. This drug was approved for the first time for medical use in 1981. Currently, it is sold as a generic medication. Trazodone is used primarily for the treatment of insomnia, anxiety disorders, and unipolar depression. Depression The primary use of the drug is for treating depression in individuals. The data, obtained from blind trials, suggests the efficacy of this pharmaceutical remedy is comparable to that of doxepin. Furthermore, it demonstrates low cardiotoxicity and anxiolytic properties. With its use, patients noticed mild side effects such as dizziness. This sedation and dizziness make this drug less acceptable for elderly patients. It is still helpful for geriatric patients who have severe insomnia or agitation. Insomnia Several clinicians often prescribe a low dose of this drug as an alternative to benzodiazepines. Trazodone is the second most prescribed drug for insomnia. There are several non-approved uses of this drug as well. The off-label uses include alcohol withdrawal, obsessive-compulsive disorder, complex regional pain syndrome, erectile dysfunction, and schizophrenia. Currently, Trazodone manufacturers offer this drug in the form of tablets with strengths varying from 25 mg to 300 mg. The distributors also offer an extended-release formulation of 300 mg and 150 mg. The drug should be taken as prescribed by the doctor. The instructions mentioned on the label should be followed accurately. The symptoms start improving after two weeks of being on this drug. While taking this medication, alcohol must not be consumed. Otherwise, the side effects may be severe. Trazodone was developed by Angelini Research Laboratories in Italy in the 1960s. It was developed after conducting mental health hypotheses in patients. It was concluded during the study that major depression was linked to a decreased pain threshold. After a series of studies, the drug was marketed by manufacturers in many countries all over the world. If you are keen on monetizing the opportunity of becoming a distributor of this drug, then head right away to Pipelinepharma. This platform is a global B2B pharmaceutical marketplace. You can quickly find products using the generic name and also use specific filters including GMP approval, dossier type, and many more. You can shortlist the leading Trazodone suppliers over this platform for your business. You will be offered assistance throughout while negotiating the terms with this drug’s supplier.

The Wholesale Cost of Trazodone?

The wholesale cost of this drug for the NHS in the United Kingdom is £7.46 per month whereas, in the US, it is $4.53. Trazodone had over 25 million prescriptions in the US alone in 2016. The prices of this pharmaceutical remedy may vary depending on the drugstore you visit.

How does Trazodone Work?

Trazodone works by acting on the neurotransmitters that regulate arousal. These include serotonin, noradrenaline, dopamine, and acetylcholine. Low doses of this drug have a sedative effect via antagonizing the 5-HT-2A receptor, H1 receptor, and alpha-1-adrenergic receptors.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Trazodone offerings for sale can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and this substance supplier that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of this drug. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where this pharmaceutical drug is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over this medicine offer with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Trazodone manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.